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Available online 8 February 2014Abstract Human bonemarrow stromal cells (BMSCs, also known as bonemarrow-derived “mesenchymal stemcells”) can establish
the hematopoietic microenvironment within heterotopic ossicles generated by transplantation at non-skeletal sites. Here we show
that non-mineralized cartilage pellets formed by hBMSCs ex vivo generate complete ossicles upon heterotopic transplantation in the
absence of exogenous scaffolds. These ossicles display a remarkable degree of architectural fidelity, showing that an exogenous
conductive scaffold is not an absolute requirement for bone formation by transplanted BMSCs. Marrow cavities within the ossicles
include erythroid, myeloid and granulopoietic lineages, clonogenic hematopoietic progenitors and phenotypic HSCs, indicating that
complete stem cell niches and hematopoiesis are established. hBMSCs (CD146+ adventitial reticular cells) are established in the
heterotopic chimeric bone marrow through a unique process of endochondral bone marrow formation, distinct from physiological
endochondral bone formation. In this process, chondrocytes remain viable and proliferate within the pellet, are released from
cartilage, and convert into bone marrow stromal cells. Once explanted in secondary culture, these cells retain phenotype and
properties of skeletal stem cells (“MSCs”), including the ability to form secondary cartilage pellets and secondary ossicles upon serial
transplantation. Ex vivo, hBMSCs initially induced to form cartilage pellets can be reestablished in adherent culture and can
modulate gene expression between cartilage and stromal cell phenotypes. These data show that so-called “cartilage differentiation”
of BMSCs in vitro is a reversible phenomenon, which is actually reverted, in vivo, to the effect of generating stromal cells supporting
the homing of hematopoietic stem cells and progenitors.© 2014 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.⁎ Corresponding author.
E-mail address: paolo.bianco@uniroma1.it (P. Bianco).
http://dx.doi.org/10.1016/j.scr.2014.01.006
1873-5061/© 2014 The Authors. Published by Elsevier B.V. OpenIntroduction
Almost everything significant that we know about the
biology of bone marrow stromal cells [also known as bone
marrow-derived “mesenchymal stem cells” (“MSCs”)] comes access under CC BY-NC-ND license.
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the past 45 years, progressive refinements of a single
seminal experiment (transplantation of bone-less fragments
of bone marrow) (Tavassoli and Crosby, 1968), have led in a
stepwise manner to the identification of “MSCs,” first as
non-hematopoietic stromal cells (bone marrow stromal
cells, BMSCs) [reviewed in Friedenstein, 1990], then to a
subset thereof noted for the ability to initiate clonal growth in
vitro (colony forming unit-fibroblast, CFU-F) (Friedenstein et
al., 1970), then to single multipotent clonogenic progenitor (a
skeletal stem cell) (Friedenstein et al., 1970; Kuznetsov et al.,
1997), and ultimately to a perisinusoidal adventitial cell
(adventitial reticular cell/pericyte), amenable to prospective
isolation (Sacchetti et al., 2007). In all of these cases, formation
of a complete heterotopic ossicle featuring bone and bone
marrow has been the fundamental readout of the experiments,
which: i) revealed the existence of a skeletogenic potential in
bone marrow, ii) ascribed it to stromal cells, iii) identified
multipotent progenitors, and iv) ultimately provided evidence
for self-renewal and in situ identity of the long-postulated, bona
fide stem cell for skeletal tissues that was at one point
inappropriately renamed “mesenchymal stem cell” [reviewed
in Bianco et al., 2013].
Different versions of the heterotopic transplantation
assays are currently in use, which differ from one another
with respect to the site of grafting (kidney subcapsular
space, subcutaneous tissue) or type of scaffold/material
employed as a carrier, which is a prerequisite for use of
human cells (Krebsbach et al., 1997). Methods for studying
human BMSCs by in vivo transplantation require the use
of mineralized, osteoconductive scaffolds (Adachi et al.,
2005; Krebsbach et al., 1997; Sacchetti et al., 2007).
Currently, the same basic principle used for generating
experimental transplants in immunocompromised mice is
directly translated into protocols designed for human
BMSC-directed bone regeneration in the clinic (Mankani et
al., 2001; Mankani et al., 2008; Quarto et al., 2001). Thus, a
variety of ceramic scaffolds are regarded as necessary and
useful for harnessing the ability of BMSCs to generate
histology-proven bone in vivo, when specifically dealing
with human rather than murine stromal progenitors
(Krebsbach et al., 1997).
A subset of human BMSCs appears to coincide with a
perisinusoidal population of clonogenic stromal cells noted
for the expression of CD146, CD105, and ALP (Sacchetti et
al., 2007). When cultured as non-differentiated cells,
loaded onto an osteoconductive scaffold, and then
transplanted in vivo, these cells are able to transfer and
organize, at heterotopic sites, a hematopoietic microenvi-
ronment. This event follows the establishment of hetero-
topic bone and a sinusoidal network, and coincides with the
establishment of a perisinusoidal compartment of CD146+
human stromal cells (Sacchetti et al., 2007). These data,
and similar data later obtained with mouse BMSCs
(Mendez-Ferrer et al., 2010) have put BMSCs at center
stage in the search for the hematopoietic “niche”-
maintaining cells. As a result, the hematopoietic stem cell
niche is currently seen as the site of a unique interplay of
two different stem cells (Bianco, 2011; Mendez-Ferrer et
al., 2010; Sacchetti et al., 2007).
While classical, the use of heterotopic transplantation
systems for investigating the biology of the hematopoieticmicroenvironment holds new promises as a result of these
recent data and views. However, to maximize the value of in
vivo transplantation in order to further elucidate the role
of BMSCs in the HSC niche, systems that facilitate the ex
vivo characterization of stromal and hematopoietic cell
populations within the heterotopic bone marrow are highly
desirable. While more refined formulations of mineralized
scaffolds (such as different proportions of HA/TCP) are
developed that may allow for ultimate complete removal of
the scaffold long term, remnants of these materials are
commonly seen in experimental transplants in immunocom-
promised mice, typically harvested at 8 weeks. This pre-
vents establishment of a completely normal architecture of
bone and marrow, and it confounds and complicates the
analysis of cell populations contained within the ossicle, as
well as the use of proper quantitative assessments of pre-
and post-grafting cell populations and whole tissue compo-
nents due to difficulties in quantitatively liberating cells
from inert ceramic scaffoldings.
Using a transplantation system free of endogenous scaffold-
ing, we show here that in vivo generation of a human
hematopoietic microenvironment (HME)/niche does not re-
quire transplantation of undifferentiated cells: by trans-
planting unmineralized cartilage pellets obtained ex vivo
from human BMSCs, a complex developmental cascade is
initiated, which is sharply distinct from endochondral ossifica-
tion. In this system, chondrocytes revert to a stromal cell
phenotype, and establish the HME/niche. Neither partner of
the dual stem cell bone marrow niche (skeletal and
hematopoietic) is actually transplanted in this system:
donor skeletal stem cells are generated (locally and in
vivo) from transplanted chondrocytes, while host (murine)
hematopoietic stem cells and hematopoietic progenitors
are recruited from the circulation.Materials and methods
Cell isolation and culture
Total nucleated cells were isolated from the washouts of
discarded bone marrow collection bags and filters used for
BM transplantation, with informed consent per institutionally
approved protocols. Cells were derived from healthy pediatric
(n = 9, aged from 9 months to 12 years) and adult donors (n =
7, aged from 17 years to 44 years) and processed as previously
described (Sacchetti et al., 2007). Human BMSC (hBMSC)
populations (at the 2nd or 3rd passage) were grown for
3 weeks as unmineralized pellets in 15 ml polypropylene
conical tubes at a density of 3 × 105 cells/tube in Chondrogenic
Differentiation Medium [CDM; DMEM-High glucose (Invitrogen,
Carlsbad, CA) supplemented with ITS™ premix (BD Biosciences,
San Jose', CA, USA), 1 mM pyruvate (Sigma-Aldrich, St. Louis,
MO), 50 μg/ml 2-phosphate–ascorbic acid (Fluka, Sigma-
Aldrich), 100 nM dexamethasone (Sigma-Aldrich), and
10 ng/ml TGFβ1 (R&D systems, Minneapolis, MN) or 10 ng/
ml TBFβ3 (Sigma-Aldrich)]. To induce mineralization for
specific experiments, pellets were cultured for 3 weeks in
CDM followed by 2 weeks in medium supplemented with
7.0 × 10−3 M β-glycerophosphate and 50 nM thyroxine (with-
out TGFβ1) (Muraglia et al., 2003). At the end of the in vitro
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histology, immunohistology and q-RT-PCR analysis. For spe-
cific experiments, cartilage pellets were collagenase-digested
and the resulting cell suspensions used as further described. In
some cases, pellets, unmineralized or mineralized, were
irradiated (30 Gy, 2.42 Gy/min) prior to transplantation.
In vivo transplantation
All animal procedures were approved by the relevant institu-
tional committee. Pellets were transplanted subcutaneously
into 8–15-week old female SCID/beige mice (C.B-17/
IcrHsd-PrkdcscidLystbg, Harlan, Inc., Indianapolis, IN) (≤16
samples/mouse) and harvested at different time points,
essentially as described for conventional BMSC-scaffold-
containing constructs (Krebsbach et al., 1997; Sacchetti et
al., 2007).
Radiography
Untransplanted cartilage pellets or harvested heterotopic
transplants were exposed to X-rays at 20 kV for 5 s in a
Faxitron MX-20 X-ray machine (Faxitron X-Ray Corp., Buffalo
Groove, IL) with Kodak MIN-R mammography film (Carestream
Health, Rochester NY, USA). Magnification used was at 5×.
Histology and immunohistology
Untransplanted cartilage pellets or heterotopic transplants
were harvested, fixed in 4% formaldehyde in phosphate buffer,
decalcified in 10% EDTA and processed for paraffin embedding,
or alternatively, samples were snap-frozen in OCT embedding
medium in liquid nitrogen and cryostat-sectioned serially. Five
micrometer thick sections were stained with hematoxylin and
eosin (Sigma-Aldrich), Safranin O-Light Green or Alcian Blue
(Sigma-Aldrich). For von Kossa staining, samples were embed-
ded undecalcified in glycol methacrylate, and the staining was
performed on 2–4 μm thick sections (Bianco et al., 1984).
Primary antibodies used for immunolocalization studies as per
established protocols are listed in Table S1. Brightfield light
microscopy images were obtained using a Zeiss Axiophot
epifluorescence microscope (Carl Zeiss, Germany). For con-
focal fluorescence microscopy (Robertson et al., 2008),
immunolabeled sections were analyzed using a Leica TCS
SP5 confocal laser scanning system (Leica Microsystems,
Mannheim, Germany). Secondary antibodies, Alexa Fluor 594
and 488, were fromMolecular Probes (Invitrogen). Nuclei were
stained by TOPRO3 (Invitrogen). In Situ cell death detection kit
(TUNEL) with fluorescein-conjugated antibodies was from
Roche Diagnostics GmbH (Mannheim, Germany).
Secondary culture of cells from untransplanted pellets
Cartilage pellets were washed in PBS and digested twice with
100 U/ml type II collagenase (Gibco, Grand Island, NY) in PBS
with 3 mM CaCl2 for 1 h at 37 °C. 2 × 105 cells obtained from
the two digestions of pooled pellets (n = 9–16) were used for
FACS analysis for human CD146 expression. The remaining
cells were seeded at clonal density (b1.6 cells/cm2) and
colony formation (N50 cells/colony) was scored at 2 weeks.Colonies surrounded by cloning cylinders were trypsin-
released and analyzed by FACS for expression of human
CD146. When relevant, cell suspensions obtained by collage-
nase digestion of pellets were magnetically depleted of the
human CD146+ fraction using MidiMACS (Miltenyi Biotech,
Bergisch Gladbach, Germany); the resulting human CD146−
fraction was used for the colony forming efficiency assay, and
other in vitro assays. Multi-colony populations and single
colonies were harvested at 2 weeks, and analyzed for human
CD146 expression by FACS analysis.RNA isolation and q-RT-PCR reaction
Total RNA was extracted using TRIZOL® reagent (Invitrogen),
following the manufacturer's instructions. 1 μg of RNA was then
reverse transcribed with the use of a SuperScript® II Reverse
Transcriptase kit (Invitrogen) in the presence of random
hexamers. q-RT-PCR reaction assays were performed in
triplicate on an ABI 7900 Real-Time PCR system thermal
cycler with the qPCR Mastermix (Applied Biosystems-
Invitrogen). All TaqMan Gene Expression assays were pro-
vided by Applied Biosystems (Table S2). The relative
expression of each gene was normalized to the reference
gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Total mRNA levels were quantified using the comparative
threshold cycle method.Secondary passage, secondary differentiation, and
secondary transplant of ossicle-derived stromal cells
After 8 weeks in vivo, heterotopic transplants were harvest-
ed and collagenase-digested and stromal cells present were
isolated by plastic adhesion. Stromal cells obtained after
2–3 weeks of culture, were characterized for the expression
of typical human BMSC markers and cultured as micromasses
under previously described chondrogenic conditions. Carti-
lage pellets obtained were either analyzed histologically, or
implanted in immunocompromised mice for 8 weeks and
then harvested for histology.Flow cytometry
After 8 weeks in vivo, heterotopic transplants were harvested
and digested with type II collagenase and single cell sus-
pensions made as described above. The cell suspension was
treated with red cell lysis buffer (except for cells used for
Ter119 staining) and stained with fluorochrome-labeled
monoclonal antibodies listed in Table S3. To identify hemato-
poietic lineage negative cells, mouse Hematopoietic Lineage
CocktaileFluor450 (from eBioscience, San Diego, CA) was used.
Analyses were performed using a FACS Canto II instrument and
FACS DIVA software (BD Biosciences, Franklin Lakes, NY). For
studies on the heterotopic bone marrow stroma, cells were
stained with PE-labeled antibodies against human antigens
listed in Table S3. Flow cytometric analysis was performed on
10,000 events with the use of a FACSCalibur cytometer and
data were analyzed using the CellQuest PRO software (BD
Biosciences). The appropriate isotype-matched antibodies
were used as negative controls in all cases.
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(h-CFE) assay
The h-CFE assay was performed in semi-solid medium
supplemented with hematopoietic cytokines. Briefly, har-
vested heterotopic ossicles were digested and filtered to
obtain single-cell suspensions. Cells were resuspended in
1 ml of MethoCult GF M3434 (StemCell Technologies,
Vancouver, BC), plated in 35 mm low-adherence plastic
dishes (Nunc, Rochester, NY), and incubated at 37 °C
and 5% CO2. Hematopoietic colonies were identified by
morphology on an inverted microscope. The nature of
individual colonies was confirmed by plucking colonies,
cytospinning the cells on glass slides, and staining with
May-Grunwald Giemsa.
Statistical analysis
Student's paired t test was used for statistical comparisons
between groups. P values less than 0.05 were considered
statistically significant.
Results
BMSC-derived chondroid pellets can generate
heterotopic ossicles with the natural architecture
of the bone/bone marrow organ
To generate heterotopic ossicles without the addition of an
exogenous scaffold, weestablished pellet cultureswith hBMSCs
(3 × 105 cells per pellet), and incubated themwith 10 ng/ml of
TGFβ1 or TGFβ3 for 3 weeks prior to in vivo transplantation
into the subcutaneous tissue of immunocompromised mice
(Fig. 1A, Fig. S1). At the end of the culture period, cartilage
pellets obtained with either TGFβ1 or TGFβ3 were essentially
identical to one another, and devoid of any mineral as assessed
by either von Kossa staining or Faxitron™ analysis (data not
shown). X-ray and histological analysis of grafts harvested at
8 weeks (n = 217, from 8 hBMSC donors) demonstrated that
complete heterotopic ossicles (i.e., structures including bone
and bone marrow) had developed in vivo (Figs. 1B–D). EachFigure 1 Chondroid pellets made from hBMSCs generate com
transplantation protocol. Multicolony-derived strains of hBMSCs are
presence of TGFβ1 for 3 weeks. Pellets are then transplanted into th
heterotopic ossicles. B) Gross appearance of 5 heterotopic ossicles (f
control transplants made with pellets generated from amniotic flu
reflects their content in hematopoietic tissue. C) Representative FA
shell of cortical bone and the inner system of bone trabecula
(radio-lucent). D) Histology of a heterotopic ossicle demonstratin
hematopoietic cells (bone marrow). (Safranin O-Light Green staining
expression of Lamin A/C, localized to the inner aspect of the nuc
Hematopoietic cells populating the marrow space are murine in ori
among mouse hematopoietic cells (mk, megakaryocyte.) F) Confoca
expressing hCD146 in the heterotopic bone marrow. Images on the
blood cells in sinusoids (sin) as well as bone. Note the adventitial p
morphology (adventitial reticular cells.) G) Heterotopic ossicles a
progenitors. Expression of hematopoietic markers in heterotopic oss
ossicle-derived cells in methylcellulose at day 14. I) Evaluation of the
MEP) by FACS analysis.pellet, and each resulting ossicle was generated by as little
as 1/7th the number of hBMSCs as typically used in a
exogenous scaffold-based transplant (3 × 105 vs. 2 × 106
cells). At variance with ossicles that develop from conven-
tional transplants of human cell-material constructs, pellet-
derived ossicles demonstrated a striking architectural resem-
blance to natural bone/marrow organs; i.e., they featured a
regular bone cortex encasing a marrow cavity filled with
hematopoietic tissue, including systems of marrow sinusoids
(Fig. 1D). Bone cells were human in origin throughout, as
demonstrated by nuclear immunoreactivity for human-
specific Lamin A/C (N95% of osteocytes and osteoblasts;
Fig. 1E); hematopoietic cells and sinusoidal endothelium
were murine (Fig. 1E), and a distinct population of human
adventitial reticular cells, immunoreactive for human CD146,
covered the abluminal surface of sinusoids (Fig. 1F). Hemato-
poietic tissue within the ossicle included erythroid, myeloid and
megakaryocytic lineages (Fig. 1G), as well as hematopoietic
clonogenic progenitors assayable in methylcellulose (Fig. 1H).
Immunophenotypic ST-HSC (LSK Flk2−CD34+, 0.029 ± 0.004%,
n = 20) and LT-HSC (LSK Flk2−CD34−, 0.012 ± 0.004%, n = 20)
(Adolfsson et al., 2001) were readily detectable in the ossicles.
Within the Lin−/c-Kit+/Sca-1− fraction, phenotypic MPP pro-
genitors (common myeloid progenitors, CMPs — FcRloCD34+;
megakaryocyte/erythrocyte lineage-restricted progeni-
tors, MEPs — FcRloCD34−; granulocyte/macrophage lineage-
restricted progenitors, GMPs — FcRhiCD34+) (Akashi et al.,
2000), were also identified (Fig. 1I).Pellet-derived ossicles are generated through
a process distinct from physiological
endochondral ossification
To elucidate how such striking architectural mimicry of
the natural bone/bone marrow organ was established, we
analyzed the development of ossicles in serially harvested
transplants. As demonstrated by von Kossa staining and
Faxitron™ analysis, cartilage was entirely unmineralized at
the end of the culture period and prior to transplantation.
However, partial mineralization of the transplanted carti-
lage pellet was detectable as early as 3 weeks post-
transplantation (Figs. 2A, D). Concurrently, mineralizedplete ossicles when transplanted in vivo. A) Scheme of the
induced to formation of cartilage by culturing as pellets in the
e subcutaneous tissue of immunocompromised mice to generate
rom 2 donors) harvested at 8 weeks, and 2 identically processed
id fibroblasts. The vivid red color of hBMSC-generated ossicles
XITRON radiogram of a heterotopic ossicle at 8 weeks. Note the
e (radio-opaque), and multiple coalescent marrow cavities
g cortical bone (bone) and a marrow cavity populated with
.) E) Human origin of the heterotopic bone, as demonstrated by
lear membrane of osteocytes in confocal fluorescence images.
gin; however, single human nuclei (arrows) are found scattered
l fluorescence images demonstrating bone marrow stromal cells
right have superimposed phase contrast images to visualize red
osition of hCD146-expressing stromal cells, and their branched
re colonized by multilineage murine hematopoietic cells and
icles. H) Morphology of colonies and cells formed by heterotopic
presence of LT-HSC, ST-HSC and MPP progenitors (GMP, CMP and
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E), while unmineralized cartilage was being invaded by
blood vessels (Figs. 2C, F). The latter process was directlyreminiscent of the formation of epiphyseal vascular canals in
fetal bone [which involves MT1-MMP-mediated, osteoclast-
free degradation of unmineralized cartilage (Holmbeck et al.,
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was progressively replaced, in the absence of local bone for-
mation, by a primitive, vascularized stromal tissue, which then
became colonized by hematopoietic cells (Figs. 2G–I). Sites of
bone formation and cartilage resorption remained spatially
segregated from one another within the developing ossicle
(Figs. 2J–L), at striking variance with the natural process of
endochondral ossification. Indeed, at no time point post-
transplantation did bone in the ossicle include a mineral-
ized cartilage core, which would mark and denote a true
endochondral process of ossification. In partially developed
ossicles, cortical bone and resorbing cartilage formed
opposite boundaries of the developing marrow, which was
“sandwiched” in between (Figs. 2J–O). Hence, the transi-
tion from cartilage pellets to heterotopic ossicles was
significantly different from the natural process of endo-
chondral ossification as commonly known. It consisted of
the replacement of cartilage by marrow (via a stromal
intermediate) rather than bone, and could be best denoted as
a unique process of “endochondral myelogenesis,” as distinct
from endochondral ossification.Survival and proliferation of chondrocytes are
required for the development of heterotopic bone
marrow (endochondral myelogenesis)
During the normal process of endochondral ossification in vivo,
chondrocytes traverse a sequence of events; i.e., proliferation,
proliferation arrest, hypertrophy and apoptosis, which pre-
cedes the removal of mineralized cartilage and its replacement
by new bone (Calvi et al., 2003; Kronenberg, 2003). As
demonstrated by TUNEL staining, no apoptosis of chondrocytes
occurred within transplanted cartilage undergoing conversion
into heterotopic ossicles (Figs. 3A,B). Ki67 labeling in pellets
harvested at 4–6 weeks revealed that ~5% of the chondrocytes
were proliferating within the cartilage pellet in vivo (Fig. 3C).
Concurrent with the ongoing replacement of cartilage by
marrow, proliferating human stromal cells (CD146+) accu-
mulated adjacent to the cartilage resorption front (Fig. 3C,
D), and an adventitial position at the wall of blood vessels
(Fig. 3E).
In vivo proliferation of chondrocytes did not translate into
growth of the ossicle relative to the originally transplanted
pellets, and cartilage itself was progressively replaced by
marrow over time (Figs. 3F–I). To determine if chondrocyte
growth had any functional bearing on the development of the
bonemarrow, we analyzed the effects of arresting proliferation
of chondrocytes prior to transplantation. To this end, cartilage
pellets were either irradiated, or induced to hypertrophy andFigure 2 Developmental stages of heterotopic ossicles. A–C) Su
20 days post-transplantation. The bulk of the tissue is still cartilage
seen at the periphery (D) as confirmed by von Kossa staining (not sh
vascular invasion of unmineralized sites (F) have begun, and a prim
view of a pellet harvested at 40 days. An extensive portion of carti
Osteoclasts (arrows) resorb mineralized cartilage, which is replac
sinusoid-type vessels, around which nascent hematopoietic foci ar
through areas of persisting cartilage and newly formed bone marr
enriched in hematopoietic cells, and has a fully developed system o
(arrows), and osteoclasts penetrate through cartilage (arrows in O);
but is associated with the appearance of stromal tissue (stroma).mineralize [by subculturing for two additional weeks under
mineralizing conditions, as described (Muraglia et al., 2003)], or
both, prior to transplantation (Figs. 4A–F). The relative volumes
of cartilage andmarrowwere thenmeasured in grafts harvested
at 8 weeks (Fig. 4C). Induction of ex vivo mineralization
significantly reduced the efficiency of conversion of the
cartilage pellet into a complete heterotopic ossicle (bone
with a bonemarrow cavity; Figs. 4A–C). Nomarrow developed
in pellets (either unmineralized or mineralized) that were
irradiated prior to transplantation (Figs. 4D–E). Cartilage
mineralization in vivo was per se unaffected in irradiated
pellets that were not induced tomineralize in vitro; formation
of an outer shell of cortical bone was also not affected
(Fig. 4F). Therefore, the ability of chondrocytes to proliferate
in vivo was required for the in vivo development of a
heterotopic marrow, but not of heterotopic bone.Human bone marrow stromal cells emerge from
cartilage in vivo
Because stromal cells are the only component of the hetero-
topic marrow contributed by the transplanted human cells,
these data suggest that chondrocytes could contribute to the
establishment of the human stroma in the heterotopic marrow
in vivo. To evaluate this possibility, we analyzed by confocal
fluorescence microscopy the histological events taking place at
the site of emergence of the newly formed stroma; i.e., at the
cartilage resorption front of developing ossicles. Human CD146
[a knownmarker of human stromal cells that is not expressed in
chondrocytes (Sacchetti et al., 2007)] and Col2 provided
convenient markers to this end (Figs. 5A–E). Chondrocytes
adjacent to the front of cartilage resorption expressed clearly
detectable membrane-associated human CD146 (Figs. 5B–E).
Stromal cells at the marrow side of the cartilage resorption
front also expressed human CD146 (Figs. 5A–E), with distinctly
higher levels of fluorescence intensity (hCD146hi) compared to
“frontline” chondrocytes (hCD146low). Chondrocytes situated
deeper, within the cartilage side of the resorption front, did not
express human CD146 (hCD146−). At the resorption front,
chondrocyte lacunae were breached by resorbing osteoclasts
[clearly visualized by autofluorescence in confocal images (Figs.
5A,D)], making a pathway to the adjacent marrow space for
the viable chondrocytes at the resorption “frontline.” Taken
together, these observations suggested that replacement of
cartilage bymarrowwas associatedwith the local emergence of
CD146-expressing stromal cells directly from the chondrocytes,
as a result of survival, modulation of phenotype, and local
migration of the cells upon the resorption of the surrounding
cartilage matrix.bmacroscopic views of cross-sections of pellets harvested at
, and there is no bone marrow. However, a mineralized phase is
own); osteoclastic resorption through mineralized sites (E), and
itive stroma appears at both types of sites. G) Submacroscopic
lage has been replaced by primitive stromal tissue (stroma). H)
ed by stromal tissue (stroma). I) The stromal tissue includes
e seen (arrow). J,K) Ossicles harvested at 60 days, sectioned
ow. This is comprised between cortical bone and cartilage, is
f sinusoids. L,O) Cartilage is undergoing osteoclastic resorption
resorption of cartilage is not coupled to deposition of new bone,
Figure 3 Survival and proliferation of chondrocytes, and generation of human bone marrow stroma within in vivo remodeling
pellets. A) Lack of TUNEL staining in chondrocytes at the cartilage/marrow interface. B) TUNEL positive control. C) Ki67 labeling in
chondrocytes and adjacent nascent stroma. D) Newly formed stromal cells expressing hCD146 at the resorbing cartilage boundary.
Left and right, same field viewed in transmitted light, H&E staining, and confocal immunofluorescence. E) Perisinusoidal stromal cells
expressing hCD146 at the resorbing cartilage boundary, transmitted light immunoperoxidase. F) Lamin A/C immunolabeling of newly
formed human stroma next to resorbing cartilage. G) Lamin A/C immunolabeling of newly formed human stroma next to resorbing
cartilage, transmitted light immunoperoxidase. Left, boundary between cartilage and stroma; right, boundary between cartilage and
hematopoietic marrow. Arrows point to human stromal cells around sinusoids. H) Size of pellets and resulting ossicles. Section area of
whole grafts before transplantation and after 8 weeks in vivo, n = 4. I) Growth of marrow relative to cartilage. Percentage of section
area occupied by cartilage and marrow, n = 4 per time point.
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“chondrocytes” ex vivo
This implied that once BMSCs differentiated into “chondrocytes”
within a pellet ex vivo, they could still revert to a stromalphenotype. To investigate this possibility further, we first
analyzed CD146 expression, vis-à-vis the expression of cartilage
markers [COL2, aggrecan (ACAN), SOX9], in non-differentiated
human CD146+ stromal cells and in pellets generated ex vivo
from parallel cultures from the same donors (Fig. 6A). Similar
Figure 4 Matrix mineralization or arrested proliferation of chondrocytes impair remodeling of cartilage into marrow. A) Pellets
cultured for 3 weeks under chondrogenic conditions were subcultured under mineralizing conditions for 2 further weeks prior to
transplantation. B) Left, X-ray of ossicle harvested at 8 weeks demonstrating a diffuse pattern of mineralization (compare with
Fig. 1), lack of a trabecular structure, and an abortive marrow cavity. Right, histology of the same ossicle demonstrating abundant
residual mineralized cartilage, and limited amounts of bone marrow. C) Histomorphometry of relative amounts of different tissues in
ossicles made from pellets that were or were not induced to mineralize prior to transplantation. Significantly more marrow and less
cartilage are observed in pellets that are transplanted unmineralized. D) Irradiation prior to transplantation of non-mineralized
pellets blocks ossicle formation. Note the absence of any bone marrow in irradiated pellets. E) Irradiation prior to transplantation
of ex vivo mineralized pellets blocks the formation of marrow. No marrow is seen in the irradiated pellet. F) Irradiation of
either unmineralized or mineralized pellets prior to transplantation does not prevent mineralization of cartilage or deposition of
cortical bone.
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cultures established by digesting pellets generated in the
same experiments and established in vitro (Fig. 6B). Quanti-
tative RT-PCR analysis demonstrated that CD146 mRNA was
highly expressed in primary BMSC cultures, and markedly
down-regulated during ex vivo chondrogenesis, while canonical
cartilage markers were concurrently upregulated as expected
(Fig. 6A). A reverse change in pattern of marker expression was
observed in cultures established by cells liberated from the
pellet compared to intact pellets (Fig. 6B). From cultures of
pellet-derived adherent cells, cartilage differentiation was
efficiently obtained upon secondary pellet culturing. In intact
pellets, CD146-expressing cells could not be demonstrated
by immunocytochemistry in untransplanted, undigested pellets,in which all canonical cartilage markers (COL2, SOX9, ACAN)
could otherwise be readily demonstrated at the protein level
(not shown). However, FACS analysis of cell suspensions
obtained fromdigested pellets revealed low levels of expression
(low counts, low MFI) of CD146 (Fig. 6C), raising the possibility
that a few non-differentiated cells could be retained in the
pellet and re-established in culture as stromal cells. However,
CD146− cells sorted from collagenase-digested untransplanted
pellets adhered to plastic, and turned on CD146 expression at
high levels within less than 2 weeks. Interestingly, a high
proportion of pellet-derived CD146− cells formed discrete
colonies at clonal density, all of which were intensely and
uniformly CD146+ (Fig. 6D). This demonstrated that pellets
contained clonogenic CD146− cells giving rise to CD146+ stromal
Figure 5 Remodeling of pre-existing cartilage into marrow stroma in vivo. Confocal fluorescence images of the resorbing cartilage/
growing marrow interface. Col2 immunoreactive cartilage is shown in red; hCD146-expressing cells in green. Osteoclasts (oc), visualized
by autofluorescence, resorb cartilage matrix and open up chondrocyte lacunae. Elongated, branched stromal cells expressing hCD146
populate the newly opened lacunae (A, D). Individual chondrocytes within lacunae near the resorption front express low levels of hCD146
(arrows in B–E). Maximum intensity of CD146 signal is seen in cells covering sinusoid-like blood vessels (sin).
668 M. Serafini et al.progenies upon growth on plastic. Taken together, these data
demonstrated that chondroid differentiation of BMSC cultures,
as achieved per standard protocols of ex vivo “differentiation,”
in fact represents a completely reversible modulation of
cartilage and stromal phenotypes in opposite directions.Chondrocyte-derived stromal cells are functional
skeletal stem cells
We then asked if the CD146+ stromal cells populating the
heterotopic ossicles in vivo, exhibited functional properties
of bone marrow stromal stem cells (bone marrow-derived
“MSCs”). To this end, the ossicles that formed following
transplantation of the cartilage pellets were harvested at
8 weeks and collagenase digested to obtain single cell
suspensions. The human CD146+ and CD146− fractions were
then sorted and plated in culture. Colony forming efficiency
assays demonstrated that CFU-Fs were segregated and
highly frequent (20%) into the hCD146+ fraction (Figs. 7A,
B), and generated clonal colonies that expressed CD146
uniformly at high levels (Fig. 7C). All “canonical” markers of“MSCs” (Dominici et al., 2006) were highly expressed in
cultures of human CD146+ cells from the heterotopic ossicles
generated by transplanted pellets (Fig. 7D). Secondary
cartilage pellets from pooled colonies were readily generat-
ed from such cultures upon exposure to chondrogenic
conditions (Figs. 7E,F). Secondary transplantation of the
secondary pellets again resulted in heterotopic ossicles
(Fig. 7G), indicating that stromal cells emerging from
chondroid pellets in vivo, and recruited to an adventitial
perisinusoidal position in the heterotopic marrow retained
clonogenicity, self-renewal capacity, and the ability to
differentiate into cartilage and bone in vivo.Discussion
“Differentiation” of stromal cells into chondrocytes is a widely
assumed property of stromal cells (in particular, for BMSCs),
and is canonically assayed in pellet cultures (Johnstone et al.,
1998; Muraglia et al., 2003; Sekiya et al., 2002). We have
shown that in vitro and in vivo, BMSC populations can be
induced to fluctuate between a stromal and a cartilage
Figure 6 Reversible modulation of cartilage and stromal phenotypes in vitro. A) Modulation of stromal and cartilage gene
expression upon induction of chondroid differentiation in primary cultures of BMSCs. q-RT-PCR. B) Reverse modulation of expression
of the same genes upon establishment of secondary cultures of BMSCs from collagenase released pellet cells of cartilage. q-RT-PCR.
C) Modulation of expression of CD146 protein. FACS analyses of the same population are shown in primary adherent culture (left),
following collagenase release from pellets (middle), and after secondary adherent culture (right). CD146 expression is modulated in
opposite direction when adherent cells are transferred to micromass (non-adherent) culture, or when micromass cultured cells are
replated in adherent culture. Low residual levels of CD146 expression are detected in micromass cultured (pellet) cells. Secondary
cultures could be induced to secondary pellet formation. D) Induction of CD146 expression in CD146− pellet cells following
collagenase release, sorting and plating as adherent cells at clonal density. FACS analysis of CD146− sorted cells prior to plating in
culture, and at 14 days of secondary culture. Colonies were pooled for FACS analysis.
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generated from cells released as CD146− chondrocytes from
the primary pellet, and secondarily passaged as CD146+ stroma.
We have also shown that stromal cells can indeed self-renew
while traversing a complex sequence of events that can include
not only serial transplantation, but alsomultiple ex vivo growth
and differentiation steps. This implies that “differentiation”
of bone marrow stromal cells into chondrocytes in vitro is a
reversible event. It remains to be determined if: a) such
reversibility is a culture epiphenomenon, in which case the
pellet culture system would not, in fact, be mirroring the
physiological chondrogenic differentiation, or b) it reflects the
behavior of chondrocytes existing in natural cartilage (at least
at specific times and sites), in which case, cartilage itself would
come to be seen as a reservoir of reversibly differentiated
cells. Multiple evidences for the fact that cartilage may not
necessarily represent terminal differentiation have been
previously given. For example, chick embryonic chondrocytes
can revert to fibroblast-like cells if plated as adherent cells;
these adherent cells can then be induced to hypertrophic
chondrocytes in suspension cultures, and an osteoblast-like
phenotype can be further induced in chondrocytes replated as
adherent cells (Castagnola et al., 1988; Castagnola et al.,1986; Galotto et al., 1994; Gentili et al., 1993; Tacchetti et al.,
1987). Chondrocytes in “metamorphic” cartilages (Holmbeck
et al., 2003) in themouse (such as parietal cartilage or Meckel's
cartilage), can activate MT1-MMP and use it to degrade and
escape from unmineralized cartilage (Holmbeck et al., 2003).
Mammalian chondrocytes located next to the bony collar in
developing bones can express a host of osteogenic markers
(Bianco et al., 1998; Riminucci et al., 1998). Instability of the
“chondrocyte” phenotype in pellets obtained from “MSCs”
had been previously noted (Dickhut et al., 2009; Pelttari et
al., 2006). In addition, dedifferentiation of chondrocytes in
cartilaginous tumors is a common event and a popular concept
in human pathology (Dorfman and Czerniak, 1998). We have
shown here that the chondrocytic phenotype induced by pellet
culture of human BMSCs is reversible in vitro and in vivo. This
reversibility can account for the origin of the marrow stromal
cells that populate the pellet-generated bone marrow in
vivo in our transplantation system that is free of exogenous
scaffolds. A remarkable degree of reversibility thus denotes
the cartilage differentiation of human BMSCs as canonically
assessed by in vitro assays. As we have shown, a chondrocyte
phenotype can be induced and then reversed, and then induced
back again. Stromal cells induced to become chondrocytes
Figure 7 Stem cell properties of human stromal cells isolated from heterotopic ossicles. A) Expression of hCD146 in collagenase
released cells from heterotopic ossicles (8 weeks). B) CFE assays of sorted CD146− and CD146− fractions, revealing restriction of
hCFU-Fs to the positive fraction, and high clonogenic efficiency. C) Uniform expression of CD146 in 4 single clones of stromal cells in
secondary culture. D) Phenotype of pooled colonies of stromal cells in secondary culture, demonstrating uniform expression of CD146
and of canonical markers of “MSCs.” E) Secondary in vitro differentiation and in vivo transplantation of secondarily cultured stromal
cells. F) chondroid pellet; G) secondary ossicle.
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their functional potential. In particular, they can revert to
hematopoiesis-supporting cells, establish a hematopoietic
stem cell niche, and resume properties characteristic of self-
renewing skeletal (“mesenchymal”) stem cells.
Ossicles generated from pellets reproduce the architec-
ture of natural bones (cortical bone, medullary cavity),
which therefore can definitely be established independent
of any instructive cue provided by any exogenous scaffolds.
Positioning bone and the marrow cavity in the precise spatial
pattern that mimics, in an artificial spheroid structure, the
natural layout must then depend on self-organization, and
reflect cues that operate either in the pre-transplantation
pellet or in the transplant in vivo. Earlier work had shown
that in cartilage pellets made from BMSCs, an outer layer of
cells expressing bone matrix proteins differentiates at the
periphery of the pellet and deposits a mineralized phaseupon subculturing under mineralizing conditions (Muraglia et
al., 2003). This suggests that the human bone that forms at
the periphery of the transplanted, unmineralized pellets is
in fact the product of cells that acquire the competence
to form bone prior to transplantation, and specifically reside
at the pellet periphery. Multiple determinants can be
envisioned to contribute to the establishment of differential
milieus in the peripheral and central portions of the pellet,
respectively, such as an outside-in oxygen gradient, or
surface tension. The general architectural plan of the ossicle
(position of the presumptive marrow “niche” and bony
cortex) generated by the pellet transplant may thus be
pre-defined in the ex vivo pellet by these particular cues.
In our system, cartilage is replaced directly by marrow, not
by bone. A spatially ordered sequence of chondrocyte prolifer-
ation, hypertrophy, and apoptosis is not reproduced in the
developing pellet-derived ossicles. Thus, the establishment
671Bone marrow and hematopoietic niches by hBMSC chondrocyte differentiation reversionof heterotopic bone and bone marrow in our system is
not dependent on mimicry of physiological endochondral
ossification. It depends on a different process, which in-
volves the removal of cartilage by chondroclasts/osteoclasts
and its replacement by marrow. The local hematopoietic
microenvironment/“niche” is established by stromal cells,
which are locally formed. Such stromal cells in our systemmay
originate in vivo from chondrocytes within the pellet, which
survive, turn on expression of the stromal marker, CD146, and
can physically escape from cartilage once their lacuna is
opened up by chondroclasts/osteoclasts.
Our data point to reversibility as a neglected dimension of
the categories “differentiation potential,” and “stemness” as
commonly applied to so-called “mesenchymal stem cells.” In
this system of non-epithelial, mesoderm-derived tissues [the
“stromal system” of Friedenstein and Owen (Owen, 1988)],
phenotypic instability andmodulation of phenotypewithin the
range of skeletal tissue types may be unique among stem
cell-ruled systems.
Supplementary data to this article can be found online at
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